HCA
CELG

Horan Capital Advisors’s Celgene Corp CELG Stock Holding History

Horan Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-20,618
Closed -$1.95M – 266
2019
Q1 		$1.95M Sell
20,618
-2,680
-12% -$234K 1.23% 36
2018
Q4 		$1.49M Sell
23,298
-4,607
-17% -$340K 1% 45
2018
Q3 		$2.5M Sell
27,905
-570
-2% -$50.4K 1.61% 28
2018
Q2 		$2.26M Buy
28,475
+310
+1% +$25.7K 1.45% 31
2018
Q1 		$2.51M Buy
28,165
+812
+3% +$78K 1.65% 29
2017
Q4 		$2.85M Sell
27,353
-930
-3% -$105K 1.86% 21
2017
Q3 		$4.12M Buy
28,283
+274
+1% +$37.3K 2.54% 6
2017
Q2 		$3.64M Buy
28,009
+881
+3% +$108K 2.48% 6
2017
Q1 		$3.38M Buy
27,128
+1,052
+4% +$126K 2.41% 10
2016
Q4 		$3.02M Buy
26,076
+18
+0.1% +$2K 2.25% 12
2016
Q3 		$2.72M Buy
26,058
+465
+2% +$50.3K 2.16% 14
2016
Q2 		$2.52M Buy
25,593
+458
+2% +$47.4K 2.05% 16
2016
Q1 		$2.52M Buy
25,135
+7,554
+43% +$778K 1.96% 17
2015
Q4 		$2.11M Sell
17,581
-1,151
-6% -$133K 1.76% 22
2015
Q3 		$2.03M Sell
18,732
-5,147
-22% -$639K 1.7% 22
2015
Q2 		$2.76M Buy
23,879
+815
+4% +$93.2K 2.33% 14
2015
Q1 		$2.66M Sell
23,064
-5,236
-19% -$626K 2.22% 14
2014
Q4 		$3.17M Buy
28,300
+505
+2% +$53.3K 2.62% 6
2014
Q3 		$2.63M Buy
27,795
+3,247
+13% +$293K 2.33% 9
2014
Q2 		$2.11M Buy
24,548
+3,250
+15% +$247K 1.93% 18
2014
Q1 		$1.49M Buy
21,298
+2,140
+11% +$169K 1.43% 34
2013
Q4 		$1.62M Buy
19,158
+750
+4% +$59.3K 1.65% 20
2013
Q3 		$1.42M Buy
18,408
+580
+3% +$40.6K 1.69% 19
2013
Q2 		$1.04M Buy
+17,828
New +$1.07M 1.58% 29

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Horan Capital Advisors's CELG Position: Q2 2019 in Review

Horan Capital Advisors sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 20,618 shares — an estimated $1.95M sold.

Horan Capital Advisors first reported a position in CELG in Q2 2013 and held it in 24 quarters. The position peaked at $4.12M in Q3 2017. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Horan Capital Advisors reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Horan Capital Advisors sold 20,618 Celgene Corp shares in Q2 2019, an estimated $1.95M.
  • Horan Capital Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 24 quarters.
  • Horan Capital Advisors's Celgene Corp position peaked at $4.12M in Q3 2017.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Horan Capital Advisors's 13F filing for Q2 2019, filed 26 Jul 2019.